Provectus Biopharmaceuticals Net Profit Margin Growth & History (PVCT)
Provectus Biopharmaceuticals's net profit margin was −1,615.81% for fiscal 2025.
View full Provectus Biopharmaceuticals company overviewProvectus Biopharmaceuticals annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,615.81% | −848.95 pp |
| 2024 | 2024-12-31 | −766.85% | −210.69 pp |
| 2023 | 2023-12-31 | −556.16% | −196.75 pp |
| 2022 | 2022-12-31 | −359.41% | — |
Provectus Biopharmaceuticals quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2025 | 2025-06-30 | −3,156.61% | −2824.50 pp |
| Q1 2025 | 2025-03-31 | −409.19% | −197.47 pp |
| Q4 2024 | 2024-12-31 | −16,517.66% | −15969.88 pp |
| Q3 2024 | 2024-09-30 | −924.28% | +188.31 pp |
| Q2 2024 | 2024-06-30 | −332.11% | +183.86 pp |
| Q1 2024 | 2024-03-31 | −211.72% | +191.87 pp |
| Q4 2023 | 2023-12-31 | −547.78% | −103.31 pp |
| Q3 2023 | 2023-09-30 | −1,112.59% | −886.07 pp |
| Q2 2023 | 2023-06-30 | −515.97% | −180.94 pp |
| Q1 2023 | 2023-03-31 | −403.59% | +145.93 pp |
| Q4 2022 | 2022-12-31 | −444.47% | — |
| Q3 2022 | 2022-09-30 | −226.51% | — |
| Q2 2022 | 2022-06-30 | −335.03% | — |
| Q1 2022 | 2022-03-31 | −549.52% | — |
Provectus Biopharmaceuticals net profit margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Provectus Biopharmaceuticals's net profit margin decreased from −359.41% to −1,615.81%, a change of −1256.40 percentage points. The latest reported quarter, Q2 2025, shows −3,156.61%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Provectus Biopharmaceuticals source filings ↗